In the largest COVID vaccine trial yet, AstraZeneca’s vaccine was 79 percent effective in preventing symptomatic infections, the company announced Monday. AstraZeneca’s vaccine has also been shown to be extremely effective at preventing the most serious outcomes from COVID-19, the company said. William Brangham discusses the latest inoculation news with Boston University’s Dr. Nahid Bhadelia.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts